Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia

Shanshan Pei(University of Colorado Anschutz Medical Campus), Craig T. Jordan(University of Colorado Anschutz Medical Campus), Ryan M. Sheridan(University of Colorado Denver), Amanda Winters(University of Colorado Denver), Biniam Adane(University of Colorado Anschutz Medical Campus), Jessica Ponder(University of Colorado Denver), Kent Riemondy(University of Colorado Denver), Mohammad Minhajuddin(University of Colorado Denver), Anagha Inguva Sheth(University of Colorado Anschutz Medical Campus), Daniel A. Pollyea(University of Colorado Denver), Haobin Ye(Fudan University), Annika Gustafson(University of Colorado Denver), James C. Costello(University of Colorado Cancer Center), Jonathan A. Gutman(University of Colorado Denver), Maria L. Amaya(University of Colorado Denver), Courtney L. Jones(University of Colorado Denver), Travis Nemkov(University of Colorado Anschutz Medical Campus), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Brett M. Stevens(University of Colorado Anschutz Medical Campus), Michael R. Savona(Vanderbilt University), Jason R. Myers(University of Rochester), Jeffrey Schowinsky(University of Colorado Denver), Austin E. Gillen(Rocky Mountain MS Center), Anna Krug(University of Colorado Anschutz Medical Campus), John M. Ashton(University of Rochester), Rui Fu(University of Colorado Denver), Haley E. Ramsey(Vanderbilt University Medical Center), Clayton A. Smith(University of Colorado Anschutz Medical Campus), Jihye Kim(University of Colorado Denver), Andrew Hammes(Colorado School of Public Health), Diana Abbott(University of Colorado Anschutz Medical Campus), Nabilah Khan(University of Colorado Anschutz Medical Campus)
Cancer Discovery
January 23, 2020
Cited by 550


Related Papers